Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06130618
Other study ID # E2-23-4633
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date March 1, 2024

Study information

Verified date November 2023
Source Ankara City Hospital Bilkent
Contact Bilge Kesikburun, Ass. Prof
Phone 0312 552 60 00
Email drbilgekb@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Piriformis Syndrome (PS) is defined as a trap neuropathy that involves compression of the sciatic nerve by the piriformis muscle, leading to a number of symptoms along with sciatic pain, initially in the hip muscles. In clinical practice, it is estimated to be between 12.2-27%. Repetitive movements with increased demand on the piriformis muscle can lead to increased muscle tension, compression of the sciatic nerve within the muscle, and the development of PS. Additionally, the anatomical structure of the piriformis muscle and the alignment and damage of adjacent structures play a role in the pathophysiology of sciatic nerve compression in PS. It is considered in pathophysiology that a morphological change (contracture, hypertrophy) may cause compression of the sciatic nerve or the relationships of different anatomical structures that change with biomechanical restrictions. Pain is observed along the ipsilateral sciatic nerve distribution due to compression of the sciatic nerve. Additionally, it has been observed that patients with PS are accompanied by weakness in the gluteal muscles, mostly in the gluteus maximus and medius muscles. Accompanying weakness has an effect on static and dynamic posture (2,3). The negative effect of pain on posture has also been shown in studies (4). Pain and muscle changes in the lower extremities also cause disability and postural instability. It has been reported that static and dynamic postural balance is reduced in PS compared to healthy controls (1). Conservative treatment for PS significantly reduces pain with a wide range of therapeutic alternatives. Since ozone injection does not have side effects or major complications, its use in the treatment of myofascial pain syndromes and piriformis syndrome is supported by studies (5). It has an analgesic effect, increasing the pain threshold by activating serotonin-mediated pathways to release endogenous opioids. Additionally, it is used safely due to its low side effect profile. In the literature, it has been shown that local anesthetic injection applications alone or in combination with steroids are effective in the treatment of PS alone due to the therapeutic effects of local anesthetic (6). This study aimed to investigate the effects of ozone and local anesthetic injection on pain, functional level and posture in patients diagnosed with PS.


Description:

It was planned as a randomized controlled study. Patients diagnosed with Priformis Syndrome will be evaluated and their demographic data and examination information will be recorded. Patients will be divided into 2 groups: ozone and lidocaine injections by computerized randomization. If there is a contraindication for ozone, the patient will be included in the lidocaine group, and similarly, if the patient has a contraindication for lidocaine, the patient will be included in the ozone group. According to G-power analysis, a total of 28 patients, 14 for each group, will be included in the study. One group will be injected with 5 mL of lidocaine 2% after localizing the piriformis muscle with USG guidance, and the other group will be injected with 5 ml - 20 μg/mL ozone after localizing the piriformis muscle with USG guidance. Pain levels of the patients will be evaluated with the visual analog scale at baseline, 1st Week, 1st Month and 3rd Month. Functional levels of all patients will be measured using the Lower Extremity Functional Scale; Posture evaluation includes trunk imbalance (sagittal/coronal imbalance), vertebral rotation, apical deviation, pelvic tilt, pelvic torsion, pelvic obliquity, kyphotic angle, lordotic angle measurement with DIERS 4D posture analyzer, static balance parameters with HUR balance device will be evaluated at baseline and at the 3rd month.


Recruitment information / eligibility

Status Recruiting
Enrollment 28
Est. completion date March 1, 2024
Est. primary completion date March 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients over 18 years of age - Patients with pain in the posterior aspect of the thigh and diagnosed with piriformis through physical examination and special tests - Knowing how to read and write Turkish - Patients with visual analog scale =5 Exclusion Criteria: - Those with a history of lumbar discopathy or a history of discopathy surgery - BMI over = 30 - Having had a corticosteroid injection within the last 3 months - Presence of neurological deficit in the lower extremity - Having a history of previous hip surgery - Having progressive or non-progressive central and peripheral nervous system disease, - Patients in pregnancy and lactation - Use of anticoagulants

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ozone
After localizing the piriformis muscle and sciatic nerve with ultrasound guidance, 5 ml - 20 µg/mL ozone will be injected.
Drug:
Lidocain
After localizing the piriformis muscle and sciatic nerve with ultrasound guidance, 5 ml - 2% lidocaine will be injected.

Locations

Country Name City State
Turkey Ankara Bilkent City Hospital Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Bouche K, Stevens V, Cambier D, Caemaert J, Danneels L. Comparison of postural control in unilateral stance between healthy controls and lumbar discectomy patients with and without pain. Eur Spine J. 2006 Apr;15(4):423-32. doi: 10.1007/s00586-005-1013-4. Epub 2005 Aug 18. — View Citation

Chon J, Kim HS, Lee JH, Yoo SD, Yun DH, Kim DH, Lee SA, Han YJ, Soh Y, Kim Y, Han YR, Won CW, Han S. Association Between Asymmetry in Knee Extension Strength and Balance in a Community-Dwelling Elderly Population: A Cross-Sectional Analysis. Ann Rehabil Med. 2018 Feb;42(1):113-119. doi: 10.5535/arm.2018.42.1.113. Epub 2018 Feb 28. — View Citation

Jardak M, Chaari F, Bouchaala F, Fendri T, Harrabi MA, Rebai H, Sahli S. Does piriformis muscle syndrome impair postural balance? A case control study. Somatosens Mot Res. 2021 Dec;38(4):315-321. doi: 10.1080/08990220.2021.1973404. Epub 2021 Sep 14. — View Citation

Misirlioglu TO, Akgun K, Palamar D, Erden MG, Erbilir T. Piriformis syndrome: comparison of the effectiveness of local anesthetic and corticosteroid injections: a double-blinded, randomized controlled study. Pain Physician. 2015 Mar-Apr;18(2):163-71. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain condition will evaluate by the visual analog scale The Visual Analog Scale (VAS) pain score (on a range of 0-10, with 0 representing no pain and 10 representing the severe pain) will evaluate. Baseline, 1. week, 1. month, 3. month
Primary posture Posture Analysis will be evaluated by DIERS formetric 4D. Participants will be positioned two meters away from the camera unit and formetric 4D projection. The device will project light stripes on the back of the participant. The back's surface will be captured on camera, converted to digital data, and displayed in three dimensions. Every scan will record 12-13 images over 6 seconds (2 Hz), and the manufacturer's recommendations will be followed for processing. Spinal reference points, measures of the spinal curve, distance and localization, imbalances of the trunk and pelvis, and spinal deviation will be measured. Spine shape parameters are expressed in millimeters, percentages, or degrees depending on the specific parameter. Baseline, 3. month
Primary Balance The static and dynamic postural control were measured by the HUR SmartBalance BTG4 system (Hur Labs, Tampere, Finland). Participants were asked to stand barefoot on the balance platform, and were requested to stand as quietly as possible, without moving and looking forward, during the measurement. The stable floor was the platform's own floor, while the unstable floor was the foam cushion given by the manufacturer with the device. Data were collected for 30 seconds. The following parameters were calculated from the center of pressure (CoP) displacement time series for static postural control: sway area, trace length, velocity, Romberg, lateral sway, anterior-posterior sway. The limits of stability (LOS) were used to determine the dynamic postural control. The patients were asked to tilt their bodies forward, backward, leftward, and rightward for 8 seconds in each direction. Baseline, 3. month
Secondary Function The Lower Extremity Functional Scale (LEFS) is a set of 20 questions designed to assess an individual's capacity to carry out routine tasks. The highest possible score is 80. The lower the score means the higher the disability. Baseline, 3. month
See also
  Status Clinical Trial Phase
Completed NCT04387877 - Graston Technique in Deep Gluteal Syndrome N/A
Completed NCT05680402 - Effects of Soft Tissue Mobilization Technique and Piriformis Muscle Stretching Among Patients Having Piriformis Syndrome N/A
Active, not recruiting NCT06437795 - Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome N/A
Completed NCT04603703 - Sacroiliac Joint Manipulation Effect in Chronic Piriformis Syndrome. N/A
Completed NCT01752179 - Kinesio Taping Technique and Trigger Point N/A
Completed NCT06435169 - Comparative Presence of Piriformis Syndrome in Patients With Lumbar Disc Bulging and Protrusion
Completed NCT05848063 - Effects of Global Hip Versus Isolated Abductors Strengthening Exercises in Patients Withsecondary Piriformis Syndrome N/A
Completed NCT05271071 - The Importance of Gluteus Maximus Muscle in Patients With Preliminary Diagnosis of Piriformis Syndrome N/A
Completed NCT04842656 - Soft Tissue Techniques in Piriformis Syndrome N/A
Not yet recruiting NCT05404607 - Effects of Fascial Distortion Model With and Without Neuromuscular Inhibition in Patients With Piriformis Syndrome N/A
Recruiting NCT06437327 - Comparison of Effectiveness Between Active Release Technique and Hold Relax Technique in Patients With Piriformis Syndrome N/A
Not yet recruiting NCT05882799 - Ultrasound-guided vs. Blinded Dry Needling for Piriformis Syndrome N/A
Recruiting NCT06102733 - Chronic Pelvic Pain in Females and Males
Not yet recruiting NCT05392933 - Investigation of the Presence of Piriformis Syndrome Accompanying Lumbar Radiculopathy N/A
Completed NCT04588779 - Graston vs Manual Myofascial Release Technique in Piriformis Syndrome. N/A
Recruiting NCT06406023 - Effectiveness of Instrument Assisted Soft Tissue Mobilization in Management of Piriformis Syndrome N/A
Completed NCT04684537 - Effect of Ultrasound-guided Piriformis Muscle Corticosteroid Injection Versus Extracorporeal Shock Wave Therapy for Piriformis Syndrome: a Randomized Control Trial N/A
Completed NCT05742633 - Comparative Effect of Active Release Technique Versus Self-myofascial Release in Improving Piriformis Syndrome N/A
Completed NCT05370378 - Effects of Hold Relax With Agonist Contraction and Active Release Therapy on Clinical Outcomes in Piriformis Syndrome N/A
Recruiting NCT05915858 - Muscle Energy Technique and Stretching Exercise in Working Pregnant Women With Piriformis Syndrome N/A